ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with at least one moderate to severe substance use disorder (not including tobacco) according to standard diagnostic criteria (DSM-5)
- People who are currently receiving treatment for a substance use disorder from a doctor or psychologist
- People who have been diagnosed with ADHD (Attention Deficit Hyperactivity Disorder) using a specific diagnostic tool called the DIVA 2.0 or DIVA-5
- People who have health insurance coverage
- People who can understand and communicate in French
- People who have signed a consent form agreeing to participate
Who may not be able to join:
- People under the age of 18
- People who are pregnant or breastfeeding
- People who have not signed the consent form
- People who have significant difficulty understanding or communicating in French
- People with severe cognitive impairment (serious difficulties with thinking, memory, or understanding)
- People with a serious medical condition that would make participation in assessments or group sessions impossible or unsafe
- People whose substance use disorder is being managed in a controlled or protected environment (such as a residential facility), currently or within the last 15 days, or expected to be during the study
- People whose only substance use disorder involves tobacco
- People who are under legal guardianship
- People who are currently detained or under a court-ordered supervision arrangement
- People who are already participating in another group-based psychological therapy during the period when this trial's group sessions are running
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Norman Therribout, PhD, Paris-Nanterre University, UR-4430 CLIPSYD ; Paris-Cité University, UMR-S-1144 INSERM; Fernand-Widal Hospital AP-HP
Phone: +33140054464
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Emotion dysregulation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.